Evidence map›Paper›PMID 41545980›Full record

ArticleBMC urology2026

Keloids as a rare complication of voluntary medical male circumcision: findings from PEPFAR's notifiable adverse events reporting system.

Stephanie Davis, Eniko Akom, Valerian Kiggundu, Sarah Nabukera, Anne Thomas, Daimon Simbeye, Oscar Ernest Rwabiyago, Suzan Mmbando, Alick Kayange, Neway Fida and 10 more

Abstract read
In one paragraph

Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Stephanie DavisDivision of Global HIV and Tuberculosis, United States Centers for Disease Control and Prevention, Atlanta, GA, USA. vic6@cdc.gov.ORCID http://orcid.org/0000-0003-4878-9701
Eniko AkomHenry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA.
Valerian KiggunduGlobal Health Consultant, Washington, DC, USA.
Sarah NabukeraOffice of Program Quality, The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), Bureau of Global Health Security and Diplomacy (GHSD), Washington, DC, USA.
Anne ThomasU.S. Department of Defense HIV/AIDS Prevention Program, Defense Health Agency, San Diego, CA, USA.
Daimon SimbeyeDivision of Global HIV and Tuberculosis, United States Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Oscar Ernest RwabiyagoDivision of Global HIV and Tuberculosis, United States Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Suzan MmbandoMinistry of Health, Dar es Salaam, Tanzania.
Alick KayangeUnited States Department of Defense, Dar es Salaam, Tanzania.
Neway FidaUnited States Agency for International Development, Dar es Salaam, Tanzania.
John MandisarisaDivision of Global HIV and Tuberculosis, United States Centers for Disease Control and Prevention, Harare, Zimbabwe.
Tungamirai MhukaZimbabwe Technical Assistance, Training and Education Center for Health (ZIMTTECH), Harare, Zimbabwe.
Wezi MsungamaDivision of Global HIV and Tuberculosis, United States Centers for Disease Control and Prevention, Lilongwe, Malawi.
Martin KapitoMinistry of Health, Lilongwe, Malawi.
Faustin MatchereUnited States Department of Defense, Lilongwe, Malawi.
Martin MaulidiUnited States Agency for International Development, Lilongwe, Malawi.
Elijah Odoyo-JuneDivision of Global HIV and Tuberculosis, United States Centers for Disease Control and Prevention, Nairobi, Kenya.
Leonard SooUnited States Agency for International Development, Nairobi, Kenya.
Ambrose JumaMinistry of Health, Nairobi, Kenya.
Todd LucasDivision of Global HIV and Tuberculosis, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKeloids are rare but challenging complications in penile surgeries, including circumcision. The President’s Emergency Plan for AIDS Relief (PEPFAR) supports voluntary medical male circumcisions (VMMC) for HIV prevention in sub-Saharan Africa, and has monitored major adverse events through its Notifiable Adverse Event Reporting system (NAER) since 2015, providing unique opportunities to understand keloid epidemiology and risk factors.

methodsAll 2015–2023 NAER keloid cases were reviewed. Variables abstracted included age at VMMC, time course, and case characteristics. Descriptive analysis and Fisher’s exact test of the association between client age (< 15 years vs. ≥ 15 years) and keloids were performed. Systematic literature searches were also conducted on case reports, outcomes and management guidelines, to produce a narrative summary and comparisons between the NAER cases and prior literature.

resultsEleven cases were reported. Clients were < 15 years old in 10/11, with median age 12 years and mean time to diagnosis 1.8 years. Clients aged 10–14 years had a significantly higher risk for keloids compared to those aged 15 and older (p = 0.0004). Case characteristics were similar to those in prior case series, as was management, except that silicone gels or sheeting were not used. Follow-up was too brief to assess outcomes.

conclusionsKeloids were a rare complication of PEPFAR-supported VMMCs. Keloids were strongly associated with age 10–14 years at circumcision as compared to older age. Programs can remind clients to return to VMMC sites even for late complications, and develop expert referral networks. Silicone gels or sheeting could represent an additional conservative management option.

Indexed as

Circumcision, MaleKeloidAdolescentAdultChildHumansMaleYoung AdultAdverse eventsCircumcisionHIV preventionKeloids

Identifiers

PMID41545980
PMCPMC12892524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.